Daniel Chastain

240 posts

Daniel Chastain

@DBChastain

Infectious diseases pharmacist | Clinical Associate Professor, UGA College of Pharmacy

Katılım Kasım 2020

140 Takip Edilen260 Takipçiler

Daniel Chastain retweetledi

Andrés Henao, MD, PhD@andhen25·21 Oca

Excited to announce our new Seminar on Leprosy just published online in @TheLancet! 🌍 @CUDeptMedicine This multicontinental collaboration provides an update on key public health & clinical aspects of this curable yet stigmatized granulomatous disease thelancet.com/journals/lance…

English

5.6K

Daniel Chastain retweetledi

Chris Bland@blandman19·15 Haz

Super job by my @UGAPharmacy colleague @DBChastain leading this review (FREE Open Access): Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review journals.sagepub.com/doi/10.1177/20…

English

973

Daniel Chastain retweetledi

Timothy Li@drtimothyli·22 May

Suggested investigation of suspected immunosuppression* *Also: recurrent deep abscesses, chronic diarrhoea with weight loss, recurring infections, infection requiring prolonged antibiotic therapy, persistent rash (particularly without recent antibiotic use). doi.org/10.1016/S2213-…

English

101

6.6K

Daniel Chastain@DBChastain·28 Mar

Thankful to have worked with @andhen25 and @GRThompsonMD in highlighting the low rates and inconsistent prescribing of PJP prophylaxis for patients on glucocorticoids ≥2 weeks in @CIDJournal

Clinical Infectious Diseases@CIDJournal

Glucocorticoids, Concomitant Immunosuppression, and PJP Prophylaxis Among U.S. Adults ✅ Just Accepted ✍️ @DBChastain 🔗 bit.ly/4j1uAW3

English

517

Daniel Chastain retweetledi

P. Brandon Bookstaver@BBookstaver_USC·27 Şub

The @AJHPOfficial ID themed issue was just released and we're (@stoverkr & I) excited to slowly share a brief synopsis of the included articles in this thread. First, a link to the full issue to browse the TOC is here: academic.oup.com/ajhp/issue/82/4 #idxposts @ASHPOfficial

English

4.1K

Daniel Chastain retweetledi

P. Brandon Bookstaver@BBookstaver_USC·26 Şub

Thanks @ASP_PharmD Here's a direct link to the ID themed issue: academic.oup.com/ajhp/issue/82/4 I'll try and provide a brief recap on the full edition over @X soon! @AJHPOfficial @AJHPOfficial @stoverkr

Brad Crane@ASP_PharmD

Lots of great articles in this ID-themed issue of @AJHPOfficial @ASHPOfficial, including guest editors @BBookstaver_USC & @stoverkr. If you're into ID Rx, this issue is for you.

English

1.8K

Daniel Chastain@DBChastain·14 Şub

Great collab w/ @UGAPharmacy students Meg George & Tonisha Gaitor, @andhen25, and @DavidCluck2, examining climate change's impact on fungal infections, incl. increased virulence, resistance, & emerging pathogens! Thanks @TAInfDis! journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease@TAInfDis

🌍🔥 Climate change is fueling the rise of fungal infections! Warmer temps, extreme weather & shifting ecosystems are making fungi more virulent & drug-resistant. With rising host susceptibility, the threat is growing. journals.sagepub.com/doi/full/10.11…

English

285

Daniel Chastain retweetledi

Chris Bland@blandman19·8 Ara

Good discussion on pros and cons of potentially shortening treatment duration for candidemia by @UGAPharmacy faculty @DBChastain. Still awaiting more data to make informed decisions on appropriate DOT. #ashp24

English

415

Daniel Chastain retweetledi

Andrés Henao, MD, PhD@andhen25·3 Ara

Inspired on our recent trips to Peru and Zimbabwe We have so much to learn from our Global South colleagues #GlobalHealth @CUDeptMedicine @E_Stenehjem @paimadhu

Therapeutic Advances in Infectious Disease@TAInfDis

📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. @andhen25 journals.sagepub.com/topic/collecti…

English

651

Daniel Chastain@DBChastain·22 Kas

@IDstewardship maybe this will help - academic.oup.com/ajhp/advance-a…

Bug Pharmacist 💊🧫 Tim Gauthier@IDstewardship

#google_vignette" target="_blank" rel="nofollow noopener">academic.oup.com/ajhp/advance-a… in @AJHPOfficial No abstract available, not open access 😢

English

277

Daniel Chastain retweetledi

Kayla Stover@stoverkr·11 Kas

Looking for a PGY2 ID residency (or CC, or Peds)? Come see @UMMCPharmacy at either the SNPhA x ACCP showcase this week or at ASHP Midyear! All PGY2 programs will be at PPS!

ACCP@ACCP

The SNPhA x ACCP Residency Showcase - take advantage of this innovative opportunity to make purposeful connections. Learn more and register: ow.ly/7XMQ50SWfKf @SNPhA

English

511

Daniel Chastain retweetledi

Joseph Sassine@JosephSassineMD·10 Kas

Our large database analysis @TriNetX of viral and fungal infections after CAR T cell therapy is out now at @CMIJournal! With @Emily_Siegrist @andhen25 @RitaWilsonDib1 @joseandres2910 @DBChastain @chiayuchiuID et al. @OUCollegeofMed #TxID #lymsm #mmsm 🧵 clinicalmicrobiologyandinfection.com/article/S1198-…

English

3.4K

Daniel Chastain retweetledi

Andrés Henao, MD, PhD@andhen25·25 Eki

My beloved Cali, Colombia is hosting the 16th meeting of the Conference of the Parties to the Convention on Biological Diversity 🌿 🦠🌍 @UNBiodiversity is spotlighting how protecting our planet's biodiversity can help prevent diseases #COP16 #GlobalHealth @CUDeptMedicine

English

1.3K

Daniel Chastain@DBChastain·21 Eki

Thanks, @hallpharms! It was a lot of fun putting these slides together and highlighting all the fantastic work being done with SAB.

English

464

Daniel Chastain@DBChastain·20 Eki

@bryan_p_white Important work by @bryan_p_white describing the variability in managing SAB (pubmed.ncbi.nlm.nih.gov/34399064/)

English

Bryan White@bryan_p_white·17 Eki

Lots of variability in SABSI treatment #IDWeek2024

English

Bryan White@bryan_p_white·17 Eki

First up @DBChastain talking about SABSI #IDWeek2024

English

Daniel Chastain@DBChastain·20 Eki

What a fantastic session with @andhen25 and @bryan_p_white! Appreciate @IDWeekmtg for the opportunity to watch virtually.

Therapeutic Advances in Infectious Disease@TAInfDis

So excited to hear from our super ⭐️ Editor in Chief @andhen25 about optimal therapy for invasive Candidiasis 🍄 #IDWeek2024

English

490

Daniel Chastain@DBChastain·20 Eki

Thank you so much @patricia_rdz_z! Appreciate you sharing the presentation.

Patricia Rodriguez Zulueta@patricia_rdz_z

#IDWeek2024 Biterapia en bacteriemia por Estafilococo aureus, en Camera 1 y Camera 2 origen endovascular está subrepresentado .8-39% no responden a monoterapia. En quien considerarla riesgo de Bacteremia persistente estratificar pacientes . Great talk @DBChastain

English

229

Daniel Chastain@DBChastain·20 Eki

You're the best @stoverkr! Thank you so much for all your support!

Kayla Stover@stoverkr

Kudos to #IDWeek2024 for providing the hybrid meeting option so I could watch this 🔥🔥 session with @DBChastain and moderated by @blandman19 on the way home.

English

423

Daniel Chastain@DBChastain·20 Eki

Well done, @ferraz_md! Congratulations!

Andrés Henao, MD, PhD@andhen25

A huge shoutout to the talented @ferraz_md for her inspiring poster and research on candidemia mortality differences by species at @IDWeekmtg 🌟 Your work is crucial in advancing our understanding and treatment of this serious infection. Bravo! 👏🦠 @CUDivofID @CUAnschutz

English

1.6K

Daniel Chastain retweetledi

Michael Calderwood, MD, MPH@CalderwoodMD·17 Eki

I love these two slides on the evidence for combination therapy in persistent MRSA and MSSA bacteremia. References in footer of each slide. #IDWeek2024

English

147

456

51.8K

Keşfet

@TheLancet @CUDeptMedicine @UGAPharmacy @andhen25 @GRThompsonMD @CIDJournal @AJHPOfficial @stoverkr